|
MFSD11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.633000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.737600E-01 |
| Normal-vs-Stage2 |
8.970000E-01 |
| Normal-vs-Stage3 |
2.535600E-01 |
| Normal-vs-Stage4 |
4.512200E-01 |
| Stage1-vs-Stage2 |
9.724000E-01 |
| Stage1-vs-Stage3 |
1.085760E-01 |
| Stage1-vs-Stage4 |
3.851200E-01 |
| Stage2-vs-Stage3 |
3.336800E-01 |
| Stage2-vs-Stage4 |
4.805000E-01 |
| Stage3-vs-Stage4 |
8.469000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.222200E-01 |
| Normal-vs-AfricanAmerican |
9.516600E-01 |
| Normal-vs-Asian |
8.272400E-02 |
| Caucasian-vs-AfricanAmerican |
9.983200E-01 |
| Caucasian-vs-Asian |
5.381600E-02 |
| AfricanAmerican-vs-Asian |
1.883420E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.375200E-01 |
| Normal-vs-Female |
9.084200E-01 |
| Male-vs-Female |
1.217170E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.115000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.540600E-01 |
| Normal-vs-Age(61-80Yrs) |
7.036600E-01 |
| Normal-vs-Age(81-100Yrs) |
5.683200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.741000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.257800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.578400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.657600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.127600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.402000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.963400E-03 |
| Classical-VS-Follicular |
2.970800E-01 |
| Classical-VS-Other |
5.932600E-01 |
| Classical-VS-Normal |
6.361200E-01 |
| Tall-VS-Follicular |
2.728400E-01 |
| Tall-VS-Other |
7.318800E-01 |
| Tall-VS-Normal |
7.149700E-02 |
| Follicular-VS-Other |
9.243400E-01 |
| Follicular-VS-Normal |
5.683400E-01 |
| Other-VS-Normal |
7.474000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.972000E-01 |
| Normal-vs-N1 |
2.119800E-02 |
| N0-vs-N1 |
1.918480E-02 |
|
|
